✦ LIBER ✦

Factors associated with system-level activities for patient safety and infection control

✍ Scribed by Haruhisa Fukuda; Yuichi Imanaka; Masahiro Hirose; Kenshi Hayashida

Book ID: 116516860
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 130 KB
Volume: 89
Category: Article
ISSN: 0168-8510
DOI: 10.1016/j.healthpol.2008.04.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Factors associated with

Corrigendum to “Factors associated with system-level activities for patient safety and infection control” [Health Policy 89 (2009) 26–36]

✍ Haruhisa Fukuda; Yuichi Imanaka; Masahiro Hirose; Kenshi Hayashida 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 82 KB

PHP91 Patient Safety Activities Associat

PHP91 Patient Safety Activities Associated with Hospital Pharmacy in A Nationwide Survey on Management System for Patient Safety

✍ M. Hirose; Y. Imanaka 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Patient- and provider-level risk factors

Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study

✍ Alyssa Finlay; Joey Lancaster; Timothy H Holtz; Karin Weyer; Abe Miranda; Martie 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 235 KB

Measuring hospital-wide activity volume

Measuring hospital-wide activity volume for patient safety and infection control: a multi-centre study in Japan

✍ Kenshi Hayashida; Yuichi Imanaka; Haruhisa Fukuda 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 252 KB

165 Factor VIIa, plasminogen activator i

165 Factor VIIa, plasminogen activator inhibitor-1, thrombomodulin and vWF levels in patients with arterial disease and patients with risk factors for arterial disease

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Vascular endothelial growth factor level

Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome

✍ M. Çekmen; C. Evereklioglu; H. Er; H. S. Inalöz; S. Doganay; ; I. H 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract **Background/aims** Vascular endothelial growth factor (VEGF) is a cytokine participating in inflammation with potent endothelial cell effects. It is produced by macrophages, neutrophils and vascular endothelial cells and can alter vessel permeability. Behçet's syndrome is a systemic in